(PDF) P1.01-96 Concurrent ALK/EGFR Alterations in Chinese

P1.01-96 Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.652

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P011 Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-58 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-61 Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers

Journal of Thoracic Oncology

Respiratory Medicine

English

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers With Concurrent TP53 and RB1 Mutations

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-56 Concurrent Mutations in Chinese Lung Cancer Patients Carrying HER2 Genomic Aberrations

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-85 the Prevalence of Different EGFR Exon20 Mutations in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-105 Lung Cancer Patients With Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases

Journal of Thoracic Oncology

Respiratory Medicine

English

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology

Respiratory Medicine

English